One of the most studied molecular systems in the regulation of tumor lymphangiogenesis is based on the interaction between vascular endothelial growth factor D (VEGF-D) and the corresponding VEGF receptor 3 (VEGFR-3), commonly expressed on the surface of lymphatic endothelial cells (10, 11). The gene discussed is VEGFD; the disease is neoplasm.